Hamilton, ON - Patients on long-term steady-dose warfarin therapy who have stable international normalized ratios (INRs) for at least six months can safely go 12 weeks between dose assessments, a new ...
Between 2 million and 3 million Americans take warfarin (Coumadin) to prevent blood clot formation, which is important in various medical conditions such as atrial fibrillation or after certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback